A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/15/9/1344/19448297/mdh343.pdf
Reference21 articles.
1. Central Cancer Registry. Annual Report.,2001
2. Antitumor efficacy of capecitabine against fluorouracil-sensitive and resistant tumors;Cao;Proc Am Soc Clin Oncol,1997
3. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue;Miwa;Eur J Cancer,1998
4. Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine;Budman;J Clin Oncol,1998
5. Phase I and pharmacological study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer;Mackean;J Clin Oncol,1998
Cited by 106 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Constructing a prognostic model for colorectal cancer with synchronous liver metastases after preoperative chemotherapy: a study based on SEER and an external validation cohort;Clinical and Translational Oncology;2024-06-04
2. Targeting cell surface glucose-regulated protein 94 in gastric cancer with an anti-GRP94 human monoclonal antibody;BMB Reports;2024-03-11
3. Case report: hepatic arterial infusion chemotherapy combined with sintilimab and lenvatinib for conversion therapy of colorectal cancer liver metastases;Frontiers in Immunology;2023-12-15
4. Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (V. 2023);Clinical Surgical Oncology;2023-06
5. Are more courses of immunochemotherapy beneficial for the short‐term outcome of locally advanced esophageal squamous cell carcinoma?;Thoracic Cancer;2023-03-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3